Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposure.

Hara N, Fujimoto N, Miyamoto Y, Yamagishi T, Asano M, Fuchimoto Y, Wada S, Ozaki S, Kishimoto T.

Respir Med Case Rep. 2015 Nov 23;16:169-71. doi: 10.1016/j.rmcr.2015.11.002. eCollection 2015.

2.

Development and Validation of a Novel Fibrosis Marker in Biliary Atresia during Infancy.

Tomita H, Fuchimoto Y, Fujino A, Hoshino K, Yamada Y, Masugi Y, Sakamoto M, Kasahara M, Kanamori Y, Nakazawa A, Yoshida F, Akatsuka S, Nakano M, Kuroda T.

Clin Transl Gastroenterol. 2015 Nov 19;6:e127. doi: 10.1038/ctg.2015.55.

3.

Endobronchial T-cell lymphoma in a patient with chronic pyothorax.

Matsumoto S, Fujimoto N, Fuchimoto Y, Asano M, Yano T, Kishimoto T.

Respirol Case Rep. 2015 Jun;3(2):44-7. doi: 10.1002/rcr2.103. Epub 2015 Apr 30.

4.

Inhibition of neutrophil elastase attenuates airway hyperresponsiveness and inflammation in a mouse model of secondary allergen challenge: neutrophil elastase inhibition attenuates allergic airway responses.

Koga H, Miyahara N, Fuchimoto Y, Ikeda G, Waseda K, Ono K, Tanimoto Y, Kataoka M, Gelfand EW, Tanimoto M, Kanehiro A.

Respir Res. 2013 Jan 24;14:8. doi: 10.1186/1465-9921-14-8.

5.

Discontinuation of living donor liver transplantation due to donor's intraoperative latex-induced anaphylactic shock.

Shinoda M, Tanabe M, Nagao K, Kitago M, Fujisaki H, Odaira M, Kawachi S, Itano O, Obara H, Matsubara K, Shimojima N, Fuchimoto Y, Hoshino K, Amagai M, Kuroda T, Kitagawa Y.

Int Surg. 2012 Oct-Dec;97(4):356-9. doi: 10.9738/CC89.1.

6.

Bilateral Pleural Effusions as an Initial Presentation in Primary Sjögren's Syndrome.

Makimoto G, Asano M, Fujimoto N, Fuchimoto Y, Ono K, Ozaki S, Taguchi K, Kishimoto T.

Case Rep Rheumatol. 2012;2012:640353. doi: 10.1155/2012/640353. Epub 2012 Nov 1.

7.

Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy.

Yoshida GJ, Fuchimoto Y, Osumi T, Shimada H, Hosaka S, Morioka H, Mukai M, Masugi Y, Sakamoto M, Kuroda T.

BMC Cancer. 2012 Oct 2;12:444. doi: 10.1186/1471-2407-12-444.

8.

Successful treatment with pemetrexed, Carboplatin, and bevacizumab for platinum-resistant adenocarcinoma of the lung.

Wada S, Fujimoto N, Gemba K, Asano M, Fuchimoto Y, Ono K, Ozaki S, Kishimoto T.

Case Rep Oncol Med. 2012;2012:821280. doi: 10.1155/2012/821280. Epub 2012 Jun 20.

9.

Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation.

Fuchimoto Y, Kanehiro A, Miyahara N, Koga H, Ikeda G, Waseda K, Tanimoto Y, Ueha S, Kataoka M, Gelfand EW, Tanimoto M.

Am J Respir Cell Mol Biol. 2011 Dec;45(6):1248-55. doi: 10.1165/rcmb.2010-0465OC. Epub 2011 Jul 14.

10.

Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease.

Waseda K, Miyahara N, Kanehiro A, Ikeda G, Koga H, Fuchimoto Y, Kurimoto E, Tanimoto Y, Kataoka M, Tanimoto M, Gelfand EW.

Am J Respir Cell Mol Biol. 2011 Oct;45(4):851-7. doi: 10.1165/rcmb.2010-0455OC. Epub 2011 Mar 18.

11.

Mixed chimerism and tolerance without whole body irradiation in a large animal model.

Fuchimoto Y, Huang CA, Yamada K, Shimizu A, Kitamura H, Colvin RB, Ferrara V, Murphy MC, Sykes M, White-Scharf M, Neville DM Jr, Sachs DH.

J Clin Invest. 2000 Jun;105(12):1779-89.

12.

Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.

Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM Jr, Sachs DH.

J Clin Invest. 2000 Jan;105(2):173-81.

Supplemental Content

Loading ...
Support Center